K

Braidwell logo

Braidwell

Crunchbase
Pitchbook
Crunchbase

Deals on record

4

Common Fundraising Type

Series A

Caris Life Sciences logo
Caris Life Sciences

Precision medicine • Molecular profiling

Woodline logo
Perceptive Advisors logo
Millennium Management logo
Ghisallo logo

Caris Life Sciences specializes in precision medicine through comprehensive molecular profiling and advanced AI technologies.

Equity
$168M
04/07/2025
Article
Perceive Pharma logo
Perceive Pharma

Pharmaceutical • Neuroprotective

Retinal Degeneration Fund logo
Johnson & Johnson logo
GV logo
Deerfield Management logo

Perceive Pharma develops novel small molecule neuroprotective therapeutics for ophthalmic diseases, including glaucoma.

Series A
$15M
02/18/2025
Article
Timberlyne Therapeutics logo
Timberlyne Therapeutics

Biopharmaceutical • Clinical-stage

Venrock Healthcare Capital Partners logo
Lilly Asia Ventures logo
Braidwell logo
Boyu Capital logo

Timberlyne Therapeutics is a biopharmaceutical company developing novel therapies for autoimmune disorders, focusing on advancing a monoclonal antibody targeting CD38.

Series A
$180M
01/10/2025
Article
Bicara Therapeutics logo
Bicara Therapeutics

Biotechnology • Clinical-stage

TPG logo
Deerfield Management logo
Braidwell logo
Aisling Capital logo

Bicara Therapeutics is a clinical-stage biotech company focused on developing BCA101, a novel bifunctional inhibitor targeting EGFR and TGF-β pathways for the treatment of various cancers.

Series C
$165M
12/12/2023
Article